AnalystsMichael G. King Jr.Michael G. King Jr.'s Stock Forecasts
AnalystsMichael G. King Jr.
Sectors:
Industries:
Analyst Ranking
Bottom 20%
#4458 out of 5548 analysts
Average Return
-10.78%
Win Rate
60%3 out of 5
Risk vs Reward
Poor
Good
Michael G. King Jr.'s 5 best and worst ratings
Michael G. King Jr. Analyst Color
Get additional color on Michael G. King Jr.'s coverage of popular stocks
Michael G. King Jr.'s Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Hemab Therapeutics Holdings IncCOAG | 1 | Strong Buy | $56.00 | +62.79% | Initiates Coverage On | 14 days ago |
Actuate Therapeutics IncACTU | 1 | Strong Buy | $6.00 | +1,163.16% | Initiates Coverage On | 3 months ago |
Atossa Therapeutics IncATOS | 1 | Strong Buy | $12.00 | +361.54% | Initiates Coverage On | 4 months ago |
Kyntra Bio IncKYNB | 1 | Strong Buy | $30.00 | +555.02% | Initiates Coverage On | 5 months ago |
Bolt Biotherapeutics IncBOLT | 1 | Strong Buy | $22.00 | +250.88% | Initiates Coverage On | 5 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.